your provider reviews the full picture with you before you start
For patients committed to long-term weight management, Ozempic can be a valuable tool
Findings In this randomized clinical trial that included 611 adults with overweight or obesity, 68 weeks treatment with once-weekly subcutaneous semaglutide vs placebo, combined with intensive behavioral therapy (and a low-calorie diet for the initial 8 weeks), resulted in reductions in body weight of 16.0% vs 5.7%, respectively
As the demand continues to grow, there continues to be a shortage of conventionally manufactured product, and compounding pharmacies are filling that need, said Davis
We provide personalized, medically supervised bioidentical hormone therapy and Perimenopause/Menopause care designed to support balance, clarity, and long-term well-being guided by both clinical insight and how you feel